A new study raises concerns about vaccine hesitancy among young survivors of cancer in the United States.
Cancer survivors often have weakened immune systems due to the cancer itself or certain treatments, so they may be at a higher risk of a severe form of Covid-19.
National organizations strongly recommend that cancer survivors receive their Covid-19 vaccine and seek the advice of their healthcare teams if unsure about vaccination.
Some adolescent and young adult cancer survivors are hesitant to get vaccinated against Covid-19, according to a new study published in JNCI Cancer SpectrumTrusted Source.
The study assessed 342 adults from the western U.S., who were diagnosed with cancer between the ages of 15 and 39 years.
While the majority of those surveyed intended to get the vaccine, more than a third (37.1%) expressed some Covid-19 vaccine hesitancy.
Stay informed with live updates on the current Covid-19 outbreak and visit our coronavirus hub for more advice on prevention and treatment.
As of June 2021, there were more than 33 million cases and nearly 600,000 deaths from Covid-19 in the U.S.
Vaccines offer one of the best tactics to control the spread of the novel coronavirus and end the pandemic.
However, an estimated 20–30% of the U.S. population exhibit some vaccine hesitancy, meaning they are cautious about receiving or would refuse a Covid-19 vaccine.